Hep Email Update Advocacy Still in Action In honor of Hep commemorating 10 years, we are spotlighting 10 inspiring activists: Ryan Clary continues his efforts to eliminate the hepatitis C epidemic. Advertisement Researchers Win Nobel Prize for Hepatitis C Discovery The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat. Women With Liver Cancer Are More Likely to Have NAFLD Than Men Women also had a higher rate of hepatocellular carcinoma in the absence of cirrhosis. How do B cells and T cells work to fight disease? Different types of white blood cells provide protection against infections and cancer. “No One Has Time for Flu” Campaign Encourages Vaccination Amid COVID-19 A flu shot can save lives and conserve medical resources for those fighting the coronavirus. #Coronavirus Get the latest updates! Advertisement Treatment News Women With Liver Cancer Are More Likely to Have NAFLD Than Men Consumption of High Fructose Drives Fatty Liver Disease Liver Stiffness After Hep C Treatment Linked to Decompensated Cirrhosis Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes Abnormal Liver Tests Linked to Worse COVID-19 Outcomes Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Features Advocacy Still in Action Trump’s Executive Order on Preexisting Conditions Lacks Teeth, Experts Say Positively Empowering Who Is Most Susceptible to COVID-19? Perseverance Continued Turning Anger Into Action Treatment News Women With Liver Cancer Are More Likely to Have NAFLD Than Men Consumption of High Fructose Drives Fatty Liver Disease Liver Stiffness After Hep C Treatment Linked to Decompensated Cirrhosis Cotadutide Improves NASH Biomarkers in Overweight People With Diabetes Abnormal Liver Tests Linked to Worse COVID-19 Outcomes Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Features Advocacy Still in Action Trump’s Executive Order on Preexisting Conditions Lacks Teeth, Experts Say Positively Empowering Who Is Most Susceptible to COVID-19? Perseverance Continued Turning Anger Into Action

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: